We investigated the relationship of functional neurocircuitries and dopamine receptor D1 (DRD1) polymorphisms in schizophrenics during a working memory task. Participants performed the Serial Item Recognition Paradigm memory task during functional magnetic resonance imaging acquisition. We performed a data-driven multivariate analysis (partial least squares) to characterize brain network (covariance) patterns. Genetic testing identi¢ed two main genotypes. Accuracy did not di¡er between the groups.
Introduction
A hallmark of schizophrenia is cognitive impairment, including working memory dysfunction. Functional magnetic resonance imaging (fMRI) studies of working memory have shown differential activations in specific areas including the dorsolateral prefrontal cortex, the anterior cingulate, inferior parietal lobule, basal ganglia and superior frontal gyrus [1] [2] [3] [4] [5] . It has been suggested that genetic differences may explain the phenomenon [6] . The dopamine receptor D1 (DRD1) is one of the candidate genes for schizophrenia and was also found to be essential for working memory [6, 7] .
In our earlier study, we found that the DRD1 polymorphic site located one kilobase upstream from the initiation codon (DdeI) was predictive of clinical response to clozapine in schizophrenia; [8] thus, we investigated whether this polymorphic site was also associated with specific functional neurocircuitries in the same population.
In a cohort of people with schizophrenia, we used partial least squares (PLS) as a data-driven tool to see whether patients with different dopaminergic genotypes recruited the same circuitry to perform a working memory task. PLS methods in neuroimaging identify areas of the brain with the strongest signal coherence [9, 10] . Rather than hypothesizing a specific relationship between fMRI signal changes and performance in the experimental conditions, a PLS analysis determines what relationship is there between the signal changes and the conditions and performance covariates, and where in the brain that relationship is in evidence.
Materials and methods

Participants
Informed consent was obtained from all participants. University of California, Irvine institutional review board approved the study protocol. Twenty-one medically stable chronic schizophrenic patients were recruited for the study. Nineteen of these participants were included in the final analysis (two were homozygous for GG allele comprising too small a sample to analyze), and they were all right handed. Six women and 13 men participated. The patients were on average 43 years of age (SD, 710.5 years) and had been ill for 13.9 years (79.1 years). All except for two patients had been ill for at least 5 years. The Positive and Negative Syndrome Scale (PANSS) and the Premorbid Verbal IQ Estimates [11] are detailed in Table 1 . All participants were on stable doses of atypical antipsychotic drugs, except for two on conventional antipsychotic agents. Six participants were also on mood stabilizers, four on antidepressants, and two on antiparkinson agents, all with doses consistent with the Food and Drug Administration approved package inserts. The PANSS scores and medications are typical for patients with chronic schizophrenia.
Genetic methods DNA was extracted from blood samples using the high-salt method [12] and polymerase chain reaction (PCR) was used to amplify the upstream DRD1 polymorphic site. The DRD1 polymorphism that was used is recognized by the restriction enzyme DdeI and is located about 1 kb upstream of the initiation codon. PCR amplification was done according to Cichon et al. [13] and DdeI restriction digest was performed according to the enzyme manufacturer's instructions (Fermentas Inc., Hamilton, Ontario, Canada). The DdeI restriction fragments were visualized using 2% agarose gel electrophoresis. No studies have yet been carried out to determine whether this site alters promoter function. Participants were divided into groups on the basis of DRD1 DdeI polymorphism, which could be AA, AG, or GG.
MRI data collection
All imaging data were collected on a 1.5T Philips scanner (Marconi/Picker Eclipse model, Philips Health Care, Andover, Massachusetts, USA). The fMRI scans consisted of a T2*-weighted gradient echo planar imaging sequence (24 cm Field of View (FOV), 28 slices, 5-mm thick with no gap, axially oriented; TR¼3 s, TE¼40 ms, 901 flip angle, 80 frames per scan) tuned to blood oxygenation level dependent (BOLD) signal. During the fMRI scans, participants performed a serial item recognition paradigm, a working memory task based on Manoach et al. [3] . The serial item recognition paradigm has been repeatedly reported to activate the dorsolateral prefrontal cortex in healthy participants and people with schizophrenia [2, 14] . Three runs (240 s each) of the working memory task were collected within the same scanning session.
The task included three conditions in a blocked design: a baseline condition, a low memory load condition and a high memory load condition. In the baseline condition blocks, participants were presented a series of arrows and asked to indicate the direction in which the arrow pointed (left or right). In both memory load conditions blocks, participants were presented with a set of numbers (presented simultaneously for 5 s), then presented with a series of 10 probe trials each consisting of a single number presented for 2 s. Participants indicated whether the probe was in the memory set of numbers, or not. In the low memory load condition, there were only two numbers in the memory set; in the high memory load condition, there were five. The memory sets were different in every block and every run. Each run consisted of nine blocks, beginning and ending with a baseline condition block.
The preprocessing steps included motion detection and correction, coregistration and normalization to a Montreal Neurological Institute brain template (Montreal Neurological Institute, Montreal, Quebec, Canada), and smoothing with an 8-mm FWHM 3D Gaussian filter (Wellcome Trust Centre for Neuroimaging, London, UK). The preprocessing steps were performed with the SPM99 software (http://www.fil.ion.ucl.ac.uk/spm/software/spm99/), using default settings where applicable [15, 16] . The motion-corrected, normalized and smoothed images were the input to the PLS analysis.
Partial least squares: image analysis
The PLS analyses used PLS version 5.0701151 (http:// www.rotman-baycrest.on.ca/). To quantitatively determine differences between circuitry of the two genotypes, a combined analysis was performed analyzing the two groups together. Separate analyses by genotype group were also performed to confirm results.
A blocked analysis of the fMRI data was used. Averages of the last six frames (18 s) of the baseline blocks were used as a baseline. Average images from the last six frames of each block during the low and high memory load conditions were included so that the hemodynamic response function could best reflect the participant's efforts at recall, rather than at the stimuli presentation. The preceding baseline block was subtracted from each memory condition block to provide a measure of BOLD signal change.
The main goal of PLS is to identify areas of the brain presenting the same activations at the same time (covariance) [9, 17] . The strongest covariance within each block is expected to describe the brain pattern related to the specific task. Singular value decomposition is performed on correlations between accuracy values averaged within each block and BOLD values at each voxel. This operation generates simultaneously a 'singular image' which is the brain image with the covarying voxels correlated with accuracy, a 'correlation profile' which is a plot expressing the relationship between accuracy and activation change in each memory condition for each group, and a 'singular value' which is a scalar number accounting for the covariance. The numerical weights within the singular image are termed saliencies; saliencies can be positive or negative. Singular image, singular value and correlational profile describe an overall pattern termed a latent variable (LV). Each singular value decomposition produces a number of LVs. The first LV accounts for the largest proportion of covariance, and thus is the primary pattern in the dataset; the second LV accounts for the next largest proportion, etc.
The significance of the singular value (i.e. whether the LV accounts for an amount of covariance that is unlikely to have arisen by chance -in essence, the strength of the LV signal relative to random noise) is determined by permutation sampling. This involves randomly reassigning the participants across groups [17] . The reliability of the saliences in the singular image (i.e. which voxels' saliences in the singular image are significantly different from zero) is determined by the bootstrap method [17] . The bootstrap procedure involves sampling the dataset with replacement to derive estimates of standard errors of the LV saliencies for each voxel.
Results
Genetic data and demographic variables Nine and 10 participants carried the AA and AG genotypes, respectively, in the DRD1. Two participants carried the GG genotype and were excluded from analysis owing to the inability to perform significance tests on such a small sample size. The distribution of males and females within the different groups was not significant (Fisher's exact test, P40.05). The mean age, symptom severity as measured by the PANSS subscores, and duration of illness did not significantly differ across genotypes (P40.05). 
Partial least squares results
This analysis was performed to contrast the brain behavior between the two groups. Of the four LVs identified by the analysis, only the first one was significant (Po0.02 by permutation testing) and stable, and it accounted for 37% of the cross-block covariance between behavior and fMRI data. The significant LV indicated the two groups had very different patterns of BOLD signal relationship with accuracy. The network (singular image thresholded for significant voxels) and the correlation profile are plotted in Fig. 1a  and b , respectively. The LV shows a different profile by genotype grouping. The voxels shown in yellow/red are positively weighted on the underlying profile, whereas the voxels shown in blue are negatively weighted on the underlying profile for the LV.
In Fig. 1a , yellow areas (positive weights) represent areas where increasing and covarying activation levels correlated with increased accuracy values within the AG group compared with the AA group; these included the temporal pole, the dorsolateral prefrontal cortex (Brodmann area 46), the inferior parietal lobule (Brodmann area 40) and the Brodmann areas 6, 21, 22 and 37. Blue areas (negative weights), in contrast, represent brain patterns that correlated with increased accuracy within the AA group relative to the AG group; these included the tectum, retrosplenial, vermis, medial amygdala, posterior inferior temporal lobe, hippocampal area, anterior insula (Brodmann area 15), Brodmann area 7, 8, 18 and 20.
The correlations specific to the dorsolateral prefrontal cortex, temporal pole, tectum and vermis are inverted for the two genotypes. The same areas show the opposite relationships with accuracy and memory between the two genotypic groups: what is positively correlated for the AA group is negatively correlated for the AG group, and vice versa. Each group analyzed individually also showed the pattern it showed in the combined group analysis.
Discussion
The patients with schizophrenia presented a similar symptomatology and working memory performance, but fell into two genotypic groups. The data-driven analysis showed that the strongest patterns of BOLD coherence identified primarily differences between the two genotypes. It appears that patients used distinct neural systems to retrieve information based on their DRD1 genotype. The AG genotype may engage a more conscious visual and verbal attentional neocortical system compared with the AA genotype to achieve an increasing level of accuracy. In contrast, the AA genotype seems to adopt a more tectopulvinar pathway, involving an unconscious visual pathway part of the posterior attentional system compared with the other.
Our study corroborated previous findings showing differential activations during working memory tasks in the dorsolateral prefrontal cortex, the anterior cingulate area, the inferior parietal lobule and the basal ganglia [1] [2] [3] [4] [5] . It is possible that the pathology cannot be simplified to a reduced or increased activation during working memory, but to specific underlying neuronal pathways determined by specific genetic mechanisms [6] .
In our study, the higher the accuracy, the more the dorsolateral prefrontal cortex seemed to be engaged in the AG and not in the AA genotype, although their performance was equivalent. This finding may contribute to aspects of the inverted U model for dopaminergic regulation perhaps based on genotype. According to the model, the dorsolateral prefrontal cortex is increasingly engaged as the working memory task becomes more difficult until it reaches a maximum capacity [18] . At the highest memory efforts, dorsolateral prefrontal cortex activation declines. Although both healthy participants and patients follow this model, the curve for people with schizophrenia peaks and falls off with lower memory load, reflecting lower working memory capacity [1] . These analyses were performed on patients with schizophrenia only. As such, the results relate to working memory issues within the context of the disease. They should not be interpreted as indicating causal relationships with the clinical diagnosis per se. Finding a genetic influence on the circuitry underlying memory performance within the patient sample, however, indicates the feasibility of using this integrated imaging-genetics approach to tease apart potentially different subtypes of the diagnosis.
A data-driven analysis was necessary to answer the question of whether or not there was a significant difference in the neurocircuitry of patients with a specific genotype. This was a rich dataset, with many possible outcomes: one group may have accounted for the most coherent pattern, whereas the other group was more variable and had no significant coherent pattern, or shown a coherent pattern in an entirely different group of brain regions. Or, the two groups may have shown the same pattern, either increasing or decreasing with memory load condition and performance. A data-driven approach extracts the most important patterns, and when followed by permutation testing and bootstrapping, indicates the reliability of those findings.
Permutation testing has been found to be particularly suitable for neuroimaging datasets with small sample sizes where parametric assumptions may not be met [19] . Our findings reflect brain-behavior patterns in a small group; however, our sample size is similar to the majority of neuroimaging studies that use multivariate analysis combined with permutation testing [10, 17, 20, 21] . Studies with a larger sample can investigate imaging-genetics patterns including a larger number of polymorphisms and genes to be able fully characterize common features of schizophrenia.
This preliminary study indicates that the DRD1 DdeI marker, which was previously identified as a potential pharmacogenetic target, may also be a useful imaginggenetics biomarker. The effect of the GG genotype is currently undetermined: It may be more like the AG group, or it may show a different pattern altogether.
Conclusion
The DRD1 (DdeI) genotype is associated with different brain patterns in schizophrenic patients. The AG genotype uses a specific network that includes the dorsolateral prefrontal cortex positively correlated with accuracy. The AA genotype, in contrast, has a negative correlation in the dorsolateral prefrontal cortex with accuracy, and has positive correlations in a different network. Therefore, even though the two groups achieve the same performance, the circuitry is possibly associated with DRD1 genotypes. This study may provide imaging-genetics insights to develop targeted therapies reflecting an individual genetic and physiological variations.
